0.46 (19 : 1 hexanes and ethyl acetate). dH (400 MHz; CDCl3) 7.89
(2H, d, J = 8.0 Hz), 7.58 (1H, s), 7.45–7.32 (6H, m), 7.16 (1H, s),
4.82 (4H, s), 3.16–2.94 (2H, m), 2.62–2.28 (5H, m), 0.97 (18H, s),
0.13 (12H, s). dC (100 MHz; CDCl3) 154.3 (q, J = 33.7 Hz), 146.4,
143.2, 142.7, 140.7, 139.4, 131.4, 130.5, 130.1, 129.5, 127.0, 126.0,
125.4, 123.7, 123.6, 121.7–107.7 (m), 65.0, 32.9 (t, J = 22.3 Hz),
28.72–23.11 (m), 21.9, 18.6, -5.2. dF (376 MHz; CDCl3) -61.93,
-67.41 (3F), -71.71, -81.28 (3F), -114.95 (2F), -122.28 (2F),
-123.29 (2F), -123.84 (2F), -126.59 (2F).
(tetrahydro-2H-pyran-2,3,4,5-tetraol) (3). To a solution of 2
(40 mg, 59.8 mmol) and mannose pentaacetate (70.4 mg, 180
mmol) in anhydrous dichloromethane (0.55 mL), BF3 Et2O (59 mg,
∑
415 mmol) was added at 0 ◦C under argon and stirred for 30
min. The reaction mixture was then warmed to room temperature
and stirred for additional 18 h followed by quenching with water.
The reaction mixture was extracted with dichloromethane and
the organic layer was dried over anhydrous sodium sulfate and
concentrated. The residue was dissolved in anhydrous methanol
(0.4 mL) followed by the addition of 5 M sodium methoxide
solution (40 mL) and stirred at room temperature, under argon, for
3 h. The reaction was quenched with the addition of Amberlyst-15
and filtered. The filtrate was concentrated and the resultant residue
was purified by reverse phase semi-prep HPLC.26 The collected
peaks with the desired compound, as identified by LC-MS, were
concentrated and lyophilized to give 3 (25.6 mg, 43%) as a white
solid. dH (400 MHz; CD3OD) 7.69 (1H, s), 7.53 (2H, s), 7.48 (1H,
s), 7.32 (1H, s), 7.19 (1H, s), 4.88 (2H, d, J = 1.7 Hz), 4.84 (13H, m,
including solvent peak), 4.64 (2H, d, J = 12.0 Hz), 3.91–3.81 (4H,
m), 3.79–3.69 (4H, m), 3.67–3.58 (4H, m), 3.10–3.00 (2H, m),
2.65–2.46 (2H, m). dC (100 MHz; CD3OD) 143.9, 143.1, 141.5,
140.5, 131.2, 130.5, 128.7, 127.5, 126.9, 124.8, 124.2–108.2 (m),
100.9, 75.2, 72.8, 72.3, 69.8, 68.8, 63.1, 33.4 (t, J = 19.2), 29.7 (q,
J = 40.4), 27.5. dF (376 MHz; CD3OD) -67.41 (3F), -82.84 (3F),
-115.74 (2F), -123.33 (2F), -124.31 (2F), -124.74 (2F), -127.75
(2F). HRMS (ESI+) for [M+Na]+; calculated: 1015.1905, found:
3-(3¢,5¢-Bis((tert-butyldimethylsilyloxy)methyl)-5-(3,3,4,4,5,5,6,
6,7,7,8,8,8-tridecafluorooctyl)biphenyl-3-yl)-3-(trifluoromethyl)-
diaziridine (18). To a solution of 17 (1.0 g, 0.948 mmol) in dry
diethyl ether (6 mL), ammonia (10 mL) was condensed at -60 ◦C
and stirred for 8 h. Ammonia was evaporated by warming the
reaction to room temperature and extracted with ether followed
by washing the organic layer with water. The ether layer was dried
over anhydrous sodium sulfate and concentrated under vacuum
followed by purification with silica column chromatography (9 : 1,
hexanes and ethyl acetate) to yield 18 (677 mg, 79%) as a white
solid. Rf 0.32 (9 : 1, hexanes and ethyl acetate). mp: 65–66 ◦C. dH
(400 MHz; CDCl3) 7.75 (1H, s), 7.53 (1H, s), 7.44 (3H, s), 7.33
(1H, s), 4.83 (4H, s), 3.02 (2H, dd, J = 10.0, 6.7 Hz), 2.85 (1H, d,
J = 8.6 Hz), 2.57–2.35 (2H, m), 2.30 (1H, d, J = 8.7 Hz), 0.98 (18H,
s), 0.14 (12H, s). dC (100 MHz; CDCl3) 143.0, 142.6, 140.6, 139.8,
133.1, 129.1, 126.9, 125.7, 123.6, 123.5, 120.0–107.6 (m), 65.0,
58.2 (q, J = 36.0 Hz), 33.1 (t, J = 21.8 Hz), 29.2–23.2 (m), 18.6,
-5.1. dF (376 MHz; CDCl3) -75.88 (3F), -81.35 (3F), -115.05
(2F), -122.34 (2F), -123.33 (2F), -123.90 (2F), -126.65 (2F).
Elemental analysis (CHN, F) calculated for C36H46F16N2O2Si2
(%)C, 48.1; H, 5.2; N, 3.1; F, 33.8; found C, 48.7; H, 5.2; N, 3.0;
F, 33.3.
1
1015.1906 (error = 0.1 ppm). Please refer to ESI† for H-COSY
and HMQC.
(3¢-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)-5¢-(2,2,2-triflu-
oro-1-[2H3]methoxy[1-2H]ethyl)biphenyl-3,5-diyl)dimethanol (19).
Photolabel 2 (3.6 mg, 5.3 mmol) was dissolved in methanol-D4
(0.6 mL) in a 5 mm NMR tube. This solution was subjected to
photoirradiation with UV light (>320 nm) and the photoactiva-
tion was followed at various time intervals using 19F NMR. After
one hour of UV irradiation the sample was transferred to a 2 mL
vial and subjected to HPLC purification27 and the peak at 20.2 min
was collected and concentrated, followed by lyophilization to give
19. dH (400 MHz; CD3OD) 7.63 (1H, s), 7.61 (1H, s), 7.55 (2H, s),
7.36 (2H, s), 4.69 (4H, s), 3.08–3.01 (2H, m), 2.71–2.42 (2H, m). dF
(376 MHz; CD3OD) -78.59 (3F, s), -82.85 (3F, t), -115.79 (2F, m),
-123.34 (2F, m), -124.32 (2F, m), -124.79 (2F, m), -127.76 (2F,
m). HRMS (ESI+) for [M+NH4]+; calculated: 694.17463, found:
694.17198 (error = -3.82 ppm).
(3¢-(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)-5¢-(3-(trifluo-
romethyl)-3H-diazirin-3-yl)biphenyl-3,5-diyl)dimethanol (2). To
a solution of 18 (0.317 g, 0.353 mmol) in dry diethyl ether
(4.5 mL), AgO (0.655 g, 5.29 mmol) was added and stirred
for 2 h. The reaction mixture was filtered and the residue was
washed with diethyl ether. The filtrate was concentrated and
dissolved in ethanol (6 mL) and pyridine p-toluenesulfonate
(177 mg, 0.706 mmol) was added to it and stirred overnight at
room temperature. After concentrating the reaction mixture under
vacuum it was extracted with ethyl acetate and washed with water.
The organic layer was dried over anhydrous sodium sulfate and
concentrated, followed by silica column chromatography (97 : 3,
dichloromethane and methanol) to give 2 (0.171 g, 72%) as a
white solid. Rf 0.38 (23 : 2, dichloromethane and methanol). Mp:
(5-(2,2,3,3,4,4,5,5,6,6,7,7,7-Tridecafluoro-1-[2H3]methoxy[1-
2H]heptyl)-1,3-phenylene)dimethanol (21). Photolabel 1 (50 mg,
101 mmol) was dissolved in methanol-D4 (5 mL) in a test tube.
This solution was subjected to photoirradiation with UV light
(>320 nm) and the photoactivation was followed at various time
intervals using 19F NMR. After 2 h of UV irradiation the sample
was subjected to HPLC purification27 and the major peak at 14.1
mins was collected and concentrated, followed by lyophilization to
give 21. dH (400 MHz, CD3OD) 7.44 (1H, s), 7.38 (2H, s), 4.85 (4H,
s, including solvent peak), 4.66 (4H, s). dC (101 MHz, CD3OD)
143.7, 133.4, 127.9, 127.5, 64.9. HRMS (ESI+) for [M+NH4]+;
calculated: 522.12464, found: 522.12456 (error = -0.16 ppm).
◦
90–91 C. dH (400 MHz; CDCl3) 7.40 (1H, s), 7.34 (3H, s), 7.17
(1H, s), 7.02 (1H, s), 4.65 (4H, s), 3.39 (2H, s), 2.92 (2H, dd,
J = 9.8, 6.7 Hz), 2.44–2.28 (2H, m). dC (100 MHz; CDCl3) 142.5,
142.3, 141.0, 140.3, 130.6, 128.8, 125.6, 125.2, 125.1, 123.9, 121.7–
107.9 (m) 64.9, 32.9 (t, J = 22.1 Hz), 28.6 (q, J = 40.5 Hz), 26.7.
dF (376 MHz; CDCl3) -65.70 (3F), -81.45 (3F), -115.09 (2F),
-122.43 (2F), -123.42 (2F), -123.93 (2F), -126.73 (2F). HRMS
(ESI+) for [M + NH4]+; calculated: 686.12945, found: 686.12865
(error = -1.18 ppm).
(2S,2¢S,3S,3¢S,4S,4¢S,5S,5¢S,6R,6¢R)-6,6¢-(3¢-(3,3,4,4,5,5,6,6,
7,7,8,8,8-Tridecafluorooctyl)-5¢-(3-(trifluoromethyl)-3H-diazirin-
3-yl)biphenyl-3,5-diyl)bis(methylene)bis(oxy)bis(methylene)bis-
(5-(2,3,3,4,4,5,5,6,6,7,7,7-Dodecafluoro-1-[2H3]methoxyhept-1-
enyl)-1,3-phenylene)dimethanol (22). Photolabel
1 (50 mg,
This journal is
The Royal Society of Chemistry 2011
Org. Biomol. Chem., 2011, 9, 6284–6292 | 6291
©